| P2093 | author name string | Jerónimo Pachón | |
| | Julián Palomino | |
| P2860 | cites work | Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection | Q28328534 |
| | Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer | Q31902665 |
| | Hospital-acquired pneumonia: risk factors, microbiology, and treatment | Q31920726 |
| | Aminoglycosides: activity and resistance | Q33548221 |
| | Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). | Q33789579 |
| | Once-daily dosing of aminoglycoside antibiotics | Q33928699 |
| | Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria | Q33976467 |
| | Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group | Q33980144 |
| | Monotherapy versus combination therapy for bacterial infections. | Q34130045 |
| | Role of aminoglycosides in the treatment of bacterial endocarditis | Q34543623 |
| | Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study | Q35136181 |
| | Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy | Q36758160 |
| | Aminoglycoside antibiotics in clinical use. | Q39634450 |
| | Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance | Q39828366 |
| | A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia | Q40596325 |
| | Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients | Q40718971 |
| | Once-daily dosing of aminoglycosides: review and recommendations for clinical practice | Q41530531 |
| | Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. | Q41696128 |
| | Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections | Q42647487 |
| | Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis | Q43857921 |
| | Once-daily tobramycin in the treatment of adult patients with cystic fibrosis | Q43897091 |
| | Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group | Q44624085 |
| | Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy | Q67973601 |
| | Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients | Q69801500 |
| | Purpose of quality standards for infectious diseases. Infectious Diseases Society of America | Q72016091 |
| | Aminoglycosides | Q72336039 |
| | Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women | Q73411176 |
| | The pharmacodynamics of aminoglycosides | Q74802269 |
| P433 | issue | 2 | |
| P407 | language of work or name | Spanish | Q1321 |
| P304 | page(s) | 105-14; QUIZ 115, 120 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Infectious Diseases and Clinical Microbiology | Q15766978 |
| P1476 | title | [Aminoglycosides]. | |
| P478 | volume | 21 | |